BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31324691)

  • 1. High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules.
    Moritz A; Anjanappa R; Wagner C; Bunk S; Hofmann M; Pszolla G; Saikia A; Garcia-Alai M; Meijers R; Rammensee HG; Springer S; Maurer D
    Sci Immunol; 2019 Jul; 4(37):. PubMed ID: 31324691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.
    Lorenz FKM; Ellinger C; Kieback E; Wilde S; Lietz M; Schendel DJ; Uckert W
    Hum Gene Ther; 2017 Dec; 28(12):1158-1168. PubMed ID: 28950731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
    Meyer M; Parpoulas C; Barthélémy T; Becker JP; Charoentong P; Lyu Y; Börsig S; Bulbuc N; Tessmer C; Weinacht L; Ibberson D; Schmidt P; Pipkorn R; Eichmüller SB; Steinberger P; Lindner K; Poschke I; Platten M; Fröhling S; Riemer AB; Hassel JC; Roberti MP; Jäger D; Zörnig I; Momburg F
    Front Immunol; 2023; 14():1294565. PubMed ID: 38239352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen.
    Thomas S; Xue SA; Bangham CR; Jakobsen BK; Morris EC; Stauss HJ
    Blood; 2011 Jul; 118(2):319-29. PubMed ID: 21606483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural-based machine learning method to classify binding affinities between TCR and peptide-MHC complexes.
    Dhusia K; Su Z; Wu Y
    Mol Immunol; 2021 Nov; 139():76-86. PubMed ID: 34455212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer.
    Audehm S; Glaser M; Pecoraro M; Bräunlein E; Mall S; Klar R; Effenberger M; Albers J; Bianchi HO; Peper J; Yusufi N; Busch DH; Stevanović S; Mann M; Antes I; Krackhardt AM
    Front Immunol; 2019; 10():1485. PubMed ID: 31316521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models.
    Margulies DH
    Curr Opin Immunol; 1997 Jun; 9(3):390-5. PubMed ID: 9203420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
    Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
    J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.
    Malecek K; Zhong S; McGary K; Yu C; Huang K; Johnson LA; Rosenberg SA; Krogsgaard M
    J Immunol Methods; 2013 Jun; 392(1-2):1-11. PubMed ID: 23500145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How T cell receptors interact with peptide-MHCs: a multiple steered molecular dynamics study.
    Cuendet MA; Zoete V; Michielin O
    Proteins; 2011 Nov; 79(11):3007-24. PubMed ID: 21989928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational design of the affinity and specificity of a therapeutic T cell receptor.
    Pierce BG; Hellman LM; Hossain M; Singh NK; Vander Kooi CW; Weng Z; Baker BM
    PLoS Comput Biol; 2014 Feb; 10(2):e1003478. PubMed ID: 24550723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction.
    Simpson AA; Mohammed F; Salim M; Tranter A; Rickinson AB; Stauss HJ; Moss PA; Steven NM; Willcox BE
    Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21176-81. PubMed ID: 22160697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
    Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
    J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay.
    Stuber G; Leder GH; Storkus WT; Lotze MT; Modrow S; Székely L; Wolf H; Klein E; Kärre K; Klein G
    Eur J Immunol; 1994 Mar; 24(3):765-8. PubMed ID: 8125143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
    Sami M; Rizkallah PJ; Dunn S; Molloy P; Moysey R; Vuidepot A; Baston E; Todorov P; Li Y; Gao F; Boulter JM; Jakobsen BK
    Protein Eng Des Sel; 2007 Aug; 20(8):397-403. PubMed ID: 17644531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes.
    Sun Y; Young MC; Woodward CH; Danon JN; Truong H; Gupta S; Winters TJ; Burslem G; Sgourakis NG
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.